Gastroenterology
Volume 138, Issue 2 , Pages 513-521.e6, February 2010

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

  • Gary L. Davis

      Affiliations

    • Division of Hepatology, Baylor University Medical Center and Baylor Regional Transplant Institute, Dallas, Texas
    • Corresponding Author InformationReprint requests Address requests for reprints to: Gary L. Davis, MD, Hepatology, 4 Roberts, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, Texas 75246. fax: (214) 820-8168
    • ,
  • Miriam J. Alter

      Affiliations

    • Infectious Disease Epidemiology Program, University of Texas Medical Branch, Galveston, Texas
    • ,
  • Hashem El–Serag

      Affiliations

    • Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas
    • ,
  • Thierry Poynard

      Affiliations

    • Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie Liver Center, Paris, France
    • ,
  • Linda W. Jennings

      Affiliations

    • Division of Hepatology, Baylor University Medical Center and Baylor Regional Transplant Institute, Dallas, Texas

Received 15 July 2009; accepted 28 September 2009. published online 26 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflicts of interest These authors disclose the following: Dr Davis received research funding from Human Genome Science, Merck, Novartis, Roche, Schering Plough, Tibotec, and Vertex Pharmaceuticals. Dr El-Serag received research funding from Schering-Plough and Bayer. Dr Poynard has a research grant from Schering Plough and equity share in BioPredictive. The remaining authors disclose no conflicts.

 Funding Sponsored by an unrestricted grant from Vertex Pharmaceutical Inc.

PII: S0016-5085(09)01885-X

doi:10.1053/j.gastro.2009.09.067

Gastroenterology
Volume 138, Issue 2 , Pages 513-521.e6, February 2010

Article Tools

* Image Usage & Resolution